about
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyCancer stem cells in small cell lung cancerScalp metastasis as the first sign of small-cell lung cancer: management and literature reviewOvercoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetaseInterleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activationBinding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7.Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Bromodomain and hedgehog pathway targets in small cell lung cancer.Erlotinib resistance in lung cancer: current progress and future perspectives.Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells.Cognitive impairments following cranial irradiation can be mitigated by treatment with a tropomyosin receptor kinase B agonist.Chemoprevention for brain metastases.Redox balance- and radiation-mediated alteration in hippocampal neurogenesis.Surfactant-based drug delivery systems for treating drug-resistant lung cancer.Present and future roles of FDG-PET/CT imaging in the management of lung cancer.Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer.miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.[Multi-factor retrospective study in 91 small cell lung cancer patients].
P2860
Q21261276-A9DCAD83-2739-4D73-B05E-0E9AC1ECF996Q26767026-DCC87DFD-0A96-43BB-8E9E-D1F9C288AEDAQ27015153-DC2236B8-5DFB-43B9-869D-AEC92030422EQ30544833-87F8F689-4A44-4749-B5DC-A268C2C26CDFQ34028454-9E3DE931-8953-420F-AF14-4F4AAA611F8EQ34383742-A570DC58-057A-4844-BFA9-460D940A5069Q35212727-3C54F934-4F68-454A-A8E4-A20D603CA604Q35234305-D62DCF41-91A0-40B2-9F3F-4C4945735B42Q35682009-F4E8DB8B-108E-4390-A916-9BB03AE4D0DCQ35713579-99DE89AC-F35B-4F68-8761-EF7129F8D2CAQ35731542-63C560A8-D249-4DA4-AD75-BE62E2C2671CQ36035933-94B88E16-78EF-432B-B013-8233ED706A5EQ36041260-CAB1A30D-C8FD-484F-B900-1113DEF59109Q36225884-D5CF0621-78BA-4089-9D06-EBB3332CD871Q36472573-EC18B4DC-C143-4770-94CD-C267840996CEQ36535682-217C87CD-AAB1-45C5-9E7B-62478542028BQ36605522-4FE0783C-C4D3-4C4E-AA74-F2C35F47A494Q36907105-EC00EA1B-9F43-48AD-9FE4-A81BEFC60948Q37065412-B68C7B2F-B4F1-4A01-B5DF-ACDFB2B9151AQ37946748-9DA9DB86-9881-40E1-B59A-7316F2BE6FD1Q37982394-411F1DC3-EEA7-4379-B64E-FA9A5A913FC5Q38228362-180B4CD5-0B18-4143-893D-52CABF74DDF8Q38819166-781A3255-9F53-4EB4-9033-4FC834EDB644Q38992148-5545C697-8BDC-4E3E-B45E-FE95E88EB6BAQ40293339-AF99F33C-0F93-4E0D-9F52-16E9A6C7E79DQ47239327-370C45A0-8331-4C84-9FE9-60790B526C8BQ47756168-FC309AF3-966F-4E5D-8698-EFE44C1CC5DDQ55430127-F2678BC9-14BA-463C-A9F4-C549C694B8F1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Small cell lung cancer: past, present, and future.
@en
Small cell lung cancer: past, present, and future.
@nl
type
label
Small cell lung cancer: past, present, and future.
@en
Small cell lung cancer: past, present, and future.
@nl
prefLabel
Small cell lung cancer: past, present, and future.
@en
Small cell lung cancer: past, present, and future.
@nl
P1476
Small cell lung cancer: past, present, and future.
@en
P2093
Estelamari Rodriguez
Rogerio C Lilenbaum
P2888
P304
P356
10.1007/S11912-010-0120-5
P577
2010-09-01T00:00:00Z